Backlund M - Search Results

1

Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1.

Karlgren M, Backlund M, Johansson I, Oscarson M, Ingelman-Sundberg M. Karlgren M, et al. Among authors: backlund m. Biochem Biophys Res Commun. 2004 Mar 12;315(3):679-85. doi: 10.1016/j.bbrc.2004.01.110. Biochem Biophys Res Commun. 2004. PMID: 14975754

2

Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.

Backlund M, Ingelman-Sundberg M. Backlund M, et al. Mol Pharmacol. 2004 Feb;65(2):416-25. doi: 10.1124/mol.65.2.416. Mol Pharmacol. 2004. PMID: 14742684

3

Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases.

Backlund M, Ingelman-Sundberg M. Backlund M, et al. Cell Signal. 2005 Jan;17(1):39-48. doi: 10.1016/j.cellsig.2004.05.010. Cell Signal. 2005. PMID: 15451023

4

Structural and mechanistic aspects of transcriptional induction of cytochrome P450 1A1 by benzimidazole derivatives in rat hepatoma H4IIE cells.

Backlund M, Weidolf L, Ingelman-Sundberg M. Backlund M, et al. Eur J Biochem. 1999 Apr;261(1):66-71. doi: 10.1046/j.1432-1327.1999.00225.x. Eur J Biochem. 1999. PMID: 10103034 Free article.

5

Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells.

Backlund M, Johansson I, Mkrtchian S, Ingelman-Sundberg M. Backlund M, et al. J Biol Chem. 1997 Dec 12;272(50):31755-63. doi: 10.1074/jbc.272.50.31755. J Biol Chem. 1997. PMID: 9395520 Free article.

6

Transcriptional and post-translational regulation of CYP1A1 by primaquine.

Werlinder V, Backlund M, Zhukov A, Ingelman-Sundberg M. Werlinder V, et al. Among authors: backlund m. J Pharmacol Exp Ther. 2001 Apr;297(1):206-14. J Pharmacol Exp Ther. 2001. PMID: 11259546

7

Functional polymorphism in the alcohol dehydrogenase 3 (ADH3) promoter.

Hedberg JJ, Backlund M, Strömberg P, Lönn S, Dahl ML, Ingelman-Sundberg M, Höög JO. Hedberg JJ, et al. Among authors: backlund m. Pharmacogenetics. 2001 Dec;11(9):815-24. doi: 10.1097/00008571-200112000-00010. Pharmacogenetics. 2001. PMID: 11740346

8

Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9.

Simoff I, Karlgren M, Backlund M, Lindström AC, Gaugaz FZ, Matsson P, Artursson P. Simoff I, et al. Among authors: backlund m. J Pharm Sci. 2016 Feb;105(2):1017-1021. doi: 10.1016/S0022-3549(15)00171-9. J Pharm Sci. 2016. PMID: 26869442

9

A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.

Karlgren M, Simoff I, Backlund M, Wegler C, Keiser M, Handin N, Müller J, Lundquist P, Jareborg AC, Oswald S, Artursson P. Karlgren M, et al. Among authors: backlund m. J Pharm Sci. 2017 Sep;106(9):2909-2913. doi: 10.1016/j.xphs.2017.04.018. Epub 2017 Apr 24. J Pharm Sci. 2017. PMID: 28450237

10

Genomic organization and promoter characterization of the gene encoding a putative endoplasmic reticulum chaperone, ERp29.

Sargsyan E, Baryshev M, Backlund M, Sharipo A, Mkrtchian S. Sargsyan E, et al. Among authors: backlund m. Gene. 2002 Feb 20;285(1-2):127-39. doi: 10.1016/s0378-1119(02)00417-1. Gene. 2002. PMID: 12039039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters